Andrew Fein
Stock Analyst at HC Wainwright & Co.
(2.19)
# 2,748
Out of 4,896 analysts
633
Total ratings
44.46%
Success rate
n/a
Average return
Main Sectors:
Stocks Rated by Andrew Fein
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| KALV KalVista Pharmaceuticals | Maintains: Buy | $20 → $27 | $15.51 | +74.08% | 15 | Jul 8, 2025 | |
| CADL Candel Therapeutics | Assumes: Buy | $23 | $6.15 | +273.98% | 1 | Jun 30, 2025 | |
| KYMR Kymera Therapeutics | Maintains: Buy | $54 → $60 | $45.21 | +32.71% | 8 | Jun 26, 2025 | |
| BIIB Biogen | Reiterates: Buy | $187 | $135.33 | +38.18% | 21 | Jun 26, 2025 | |
| ACAD ACADIA Pharmaceuticals | Reiterates: Buy | $32 | $22.06 | +45.06% | 20 | Jun 26, 2025 | |
| VRTX Vertex Pharmaceuticals | Reiterates: Buy | $550 | $479.53 | +14.70% | 27 | Jun 23, 2025 | |
| INSM Insmed | Maintains: Buy | $90 → $120 | $96.66 | +24.15% | 15 | Jun 11, 2025 | |
| PEPG PepGen | Maintains: Buy | $14 → $8 | $1.25 | +540.00% | 13 | May 29, 2025 | |
| SVRA Savara | Downgrades: Neutral | $6 → $2 | $2.30 | -13.04% | 13 | May 29, 2025 | |
| LQDA Liquidia | Maintains: Buy | $29 → $35 | $14.15 | +147.35% | 14 | May 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $14 → $8 | $8.04 | -0.50% | 14 | May 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $30 → $14 | $6.57 | +113.09% | 18 | May 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $47 → $35 | $12.04 | +190.70% | 14 | May 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $20 → $14 | $2.80 | +400.00% | 15 | May 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $80 → $75 | $18.90 | +296.83% | 5 | May 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $72 → $68 | $31.47 | +116.08% | 5 | May 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $7 → $10 | $1.72 | +481.40% | 10 | May 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $46 → $38 | $8.80 | +331.82% | 12 | May 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $12 → $16 | $7.39 | +116.51% | 20 | May 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $40 → $25 | $14.47 | +72.77% | 15 | May 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $80 → $32 | $15.35 | +108.47% | 22 | May 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $30 | $8.88 | +237.84% | 10 | May 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $425 | $300.16 | +41.59% | 15 | May 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $7 → $16 | $10.85 | +47.47% | 12 | May 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $81 → $24 | $7.89 | +204.18% | 19 | May 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $135 | $129.33 | +4.38% | 18 | May 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $16 → $12 | $2.11 | +468.72% | 16 | May 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $38 | $26.94 | +41.05% | 6 | Apr 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $8 | $2.87 | +178.75% | 2 | Apr 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $185 → $168 | $134.92 | +24.52% | 20 | Apr 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $8 → $7 | $2.05 | +241.46% | 13 | Apr 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $15 → $11 | $1.30 | +746.15% | 11 | Mar 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $10 | $1.37 | +629.93% | 18 | Mar 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $22 | $7.95 | +176.73% | 12 | Mar 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $12 → $2 | $0.82 | +144.56% | 16 | Mar 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $10 → $12 | $2.36 | +408.47% | 12 | Mar 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $13 | $5.40 | +140.74% | 14 | Mar 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $11 | $8.02 | +37.16% | 10 | Mar 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $23 | $3.12 | +637.18% | 14 | Mar 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $15 | $1.84 | +715.22% | 13 | Mar 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $85 | $55.11 | +54.24% | 16 | Mar 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $35 | $21.85 | +60.18% | 14 | Feb 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | $4 | $8.01 | -50.06% | 17 | Feb 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $75 | $8.36 | +797.13% | 7 | Feb 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $75 | $27.11 | +176.65% | 1 | Jan 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $8 | $0.10 | +7,820.79% | 7 | Aug 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $17 → $7 | $1.99 | +251.76% | 6 | Nov 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $10 | $6.44 | +55.28% | 5 | Aug 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $100 → $40 | $2.68 | +1,392.54% | 3 | Feb 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $150 | $1.02 | +14,605.88% | 1 | Jan 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $200 → $60 | $17.25 | +247.83% | 4 | May 5, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $15 | $4.80 | +212.50% | 1 | Apr 27, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $80 → $40 | $1.81 | +2,109.94% | 3 | Mar 16, 2022 |
KalVista Pharmaceuticals
Jul 8, 2025
Maintains: Buy
Price Target: $20 → $27
Current: $15.51
Upside: +74.08%
Candel Therapeutics
Jun 30, 2025
Assumes: Buy
Price Target: $23
Current: $6.15
Upside: +273.98%
Kymera Therapeutics
Jun 26, 2025
Maintains: Buy
Price Target: $54 → $60
Current: $45.21
Upside: +32.71%
Biogen
Jun 26, 2025
Reiterates: Buy
Price Target: $187
Current: $135.33
Upside: +38.18%
ACADIA Pharmaceuticals
Jun 26, 2025
Reiterates: Buy
Price Target: $32
Current: $22.06
Upside: +45.06%
Vertex Pharmaceuticals
Jun 23, 2025
Reiterates: Buy
Price Target: $550
Current: $479.53
Upside: +14.70%
Insmed
Jun 11, 2025
Maintains: Buy
Price Target: $90 → $120
Current: $96.66
Upside: +24.15%
PepGen
May 29, 2025
Maintains: Buy
Price Target: $14 → $8
Current: $1.25
Upside: +540.00%
Savara
May 29, 2025
Downgrades: Neutral
Price Target: $6 → $2
Current: $2.30
Upside: -13.04%
Liquidia
May 28, 2025
Maintains: Buy
Price Target: $29 → $35
Current: $14.15
Upside: +147.35%
May 27, 2025
Downgrades: Neutral
Price Target: $14 → $8
Current: $8.04
Upside: -0.50%
May 27, 2025
Maintains: Buy
Price Target: $30 → $14
Current: $6.57
Upside: +113.09%
May 14, 2025
Maintains: Buy
Price Target: $47 → $35
Current: $12.04
Upside: +190.70%
May 14, 2025
Maintains: Buy
Price Target: $20 → $14
Current: $2.80
Upside: +400.00%
May 12, 2025
Maintains: Buy
Price Target: $80 → $75
Current: $18.90
Upside: +296.83%
May 12, 2025
Maintains: Buy
Price Target: $72 → $68
Current: $31.47
Upside: +116.08%
May 9, 2025
Maintains: Buy
Price Target: $7 → $10
Current: $1.72
Upside: +481.40%
May 9, 2025
Maintains: Buy
Price Target: $46 → $38
Current: $8.80
Upside: +331.82%
May 9, 2025
Maintains: Buy
Price Target: $12 → $16
Current: $7.39
Upside: +116.51%
May 8, 2025
Maintains: Buy
Price Target: $40 → $25
Current: $14.47
Upside: +72.77%
May 7, 2025
Maintains: Buy
Price Target: $80 → $32
Current: $15.35
Upside: +108.47%
May 6, 2025
Reiterates: Buy
Price Target: $30
Current: $8.88
Upside: +237.84%
May 5, 2025
Reiterates: Buy
Price Target: $425
Current: $300.16
Upside: +41.59%
May 5, 2025
Maintains: Buy
Price Target: $7 → $16
Current: $10.85
Upside: +47.47%
May 2, 2025
Maintains: Buy
Price Target: $81 → $24
Current: $7.89
Upside: +204.18%
May 2, 2025
Reiterates: Buy
Price Target: $135
Current: $129.33
Upside: +4.38%
May 1, 2025
Maintains: Buy
Price Target: $16 → $12
Current: $2.11
Upside: +468.72%
Apr 30, 2025
Reiterates: Buy
Price Target: $38
Current: $26.94
Upside: +41.05%
Apr 28, 2025
Reiterates: Buy
Price Target: $8
Current: $2.87
Upside: +178.75%
Apr 22, 2025
Maintains: Buy
Price Target: $185 → $168
Current: $134.92
Upside: +24.52%
Apr 4, 2025
Maintains: Buy
Price Target: $8 → $7
Current: $2.05
Upside: +241.46%
Mar 28, 2025
Maintains: Buy
Price Target: $15 → $11
Current: $1.30
Upside: +746.15%
Mar 27, 2025
Reiterates: Buy
Price Target: $10
Current: $1.37
Upside: +629.93%
Mar 26, 2025
Reiterates: Buy
Price Target: $22
Current: $7.95
Upside: +176.73%
Mar 17, 2025
Downgrades: Neutral
Price Target: $12 → $2
Current: $0.82
Upside: +144.56%
Mar 14, 2025
Maintains: Buy
Price Target: $10 → $12
Current: $2.36
Upside: +408.47%
Mar 7, 2025
Reiterates: Buy
Price Target: $13
Current: $5.40
Upside: +140.74%
Mar 6, 2025
Reiterates: Buy
Price Target: $11
Current: $8.02
Upside: +37.16%
Mar 6, 2025
Reiterates: Buy
Price Target: $23
Current: $3.12
Upside: +637.18%
Mar 6, 2025
Reiterates: Buy
Price Target: $15
Current: $1.84
Upside: +715.22%
Mar 3, 2025
Reiterates: Buy
Price Target: $85
Current: $55.11
Upside: +54.24%
Feb 28, 2025
Reiterates: Buy
Price Target: $35
Current: $21.85
Upside: +60.18%
Feb 26, 2025
Reiterates: Neutral
Price Target: $4
Current: $8.01
Upside: -50.06%
Feb 18, 2025
Reiterates: Buy
Price Target: $75
Current: $8.36
Upside: +797.13%
Jan 13, 2025
Reiterates: Buy
Price Target: $75
Current: $27.11
Upside: +176.65%
Aug 8, 2024
Reiterates: Buy
Price Target: $8
Current: $0.10
Upside: +7,820.79%
Nov 2, 2023
Maintains: Buy
Price Target: $17 → $7
Current: $1.99
Upside: +251.76%
Aug 15, 2023
Reiterates: Buy
Price Target: $10
Current: $6.44
Upside: +55.28%
Feb 13, 2023
Maintains: Buy
Price Target: $100 → $40
Current: $2.68
Upside: +1,392.54%
Jan 31, 2023
Reiterates: Buy
Price Target: $150
Current: $1.02
Upside: +14,605.88%
May 5, 2022
Downgrades: Neutral
Price Target: $200 → $60
Current: $17.25
Upside: +247.83%
Apr 27, 2022
Assumes: Buy
Price Target: $15
Current: $4.80
Upside: +212.50%
Mar 16, 2022
Maintains: Neutral
Price Target: $80 → $40
Current: $1.81
Upside: +2,109.94%